icon-    folder.gif   Conference Reports for NATAP  
 
  IAS 2019: Conference on HIV Pathogenesis
Treatment and Prevention
Mexico City
July 21-24 2019
Back grey_arrow_rt.gif
 
 
 
A SWITCH TO DOLUTEGRAVIR IN COMBINATION WITH BOOSTED DARUNAVIR IS SAFE AND EFFECTIVE IN SUPPRESSED PATIENTS WITH HIV - A SUBANALYSIS OF THE DUALIS STUDY
 
 
  Reported by Jules Levin
10th IAS Conference on HIV Science (IAS 2019), July 21-24, 2019, Mexico City

0802191

0802192

0802193

0802194